PKM and Stroke: Furthermore, the proliferation ability of oligodendrocytes administrated with stroke or PSD was reduced, whereas PKM2 restored the proliferation ability of oligodendrocytes administrated with PSD in a dose‐dependent manner (p < 0.01) (Figure 2b).